Current Net Margin
-1658.94%
Monte Rosa Therapeutics, Inc. currently has a net profit margin of -1658.94%.
Financial Fundamentals
GLUE • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.05 | -1658.94% | ▼144684 |
| 2025-09-30 | 0.01 | -0.03 | -212.10% | ▼15909 |
| 2025-06-30 | 0.02 | -0.01 | -53.01% | ▼10821 |
| 2025-03-31 | 0.08 | 0.05 | 55.20% | ▲3305 |
| 2024-12-31 | 0.06 | 0.01 | 22.16% | ▲28104 |
| 2024-09-30 | 0.01 | -0.02 | -258.89% | ▲38669 |
| 2024-06-30 | 0.00 | -0.03 | -645.58% | ▲235893 |
| 2024-03-31 | 0.00 | -0.03 | -3004.51% | — |
| 2023-12-31 | 0.00 | -0.03 | — | — |
| 2023-09-30 | 0.00 | -0.03 | — | — |
| 2023-06-30 | 0.00 | -0.04 | — | — |
| 2023-03-31 | 0.00 | -0.03 | — | — |
| 2022-12-31 | 0.00 | -0.03 | — | — |
| 2022-09-30 | 0.00 | -0.03 | — | — |
| 2022-06-30 | 0.00 | -0.03 | — | — |
| 2022-03-31 | 0.00 | -0.02 | — | — |
| 2021-12-31 | 0.00 | -0.02 | — | — |
| 2021-09-30 | 0.00 | -0.02 | — | — |
| 2021-06-30 | 0.00 | -0.02 | — | — |
| 2021-03-31 | 0.00 | -0.01 | — | — |
| 2020-12-31 | 0.00 | -0.02 | — | — |
| 2020-09-30 | 0.00 | -0.01 | — | — |
| 2020-06-30 | 0.00 | -0.01 | — | — |
| 2020-03-31 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.